Topical Acne-Non-Retinoid Products
Customize your policy alerts
Sign up for Cigna Policy IP0166 alerts
Get alerted when Policy IP0166 changes without checking for updates manually.
Monitor payer policy activity
Defines medical necessity and coverage criteria for topical non‑retinoid acne products (e.g., clindamycin, minocycline, combination benzoyl peroxide products) for Cigna‑administered health plans.
Removed Dapsone products (Aczone) medical necessity criteria from this policy.
Employer Preferred Product table: Removed Onexton preferred product requirements.
No criteria changes noted for recent reviews leading to effective date 08/15/2026.
OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.